NEPHROPLUS · NSE,BSE · Healthcare
Nephrocare Health IPO listed on 17 Dec 2025 on NSE,BSE at ₹490.00, a gain of 6.52% over the issue price of ₹460.00. The IPO was subscribed 9.15x overall.
Nephrocare Health IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 10 Dec 2025 |
| IPO Close Date | 12 Dec 2025 |
| Basis of Allotment | 15 Dec 2025 |
| Initiation of Refunds | 16 Dec 2025 |
| Credit of Shares to Demat | 16 Dec 2025 |
| Listing Date | 17 Dec 2025 |
Listing day gain
+6.52%
Listed at ₹490 (issue ₹460)
Issue
₹460
Listing
₹490
Current
₹471.25
+2.45% vs issue
Day range
₹463.8 – ₹499
Issue Size
₹871.04 Cr
Issue Price
₹438 – ₹460
Face Value
₹2/share
Market Lot
32 shares
Retail Min Investment
₹14,720
Listing At
NSE,BSE
Sale Type
both
Fresh Issue
₹353.4 Cr
Offer for Sale
₹517.64 Cr
Issue Type
book building
Open Date
10 Dec
Close Date
12 Dec
Allotment
15 Dec
Listing
17 Dec
Last updated: 11 months ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 17 Dec 2025 Latest | ₹460 | ₹40 | ₹500 | ₹40 |
8.7%
|
12:00 PM |
| 16 Dec 2025 | ₹460 | ₹37 | ₹497 | ₹37 |
8.04%
|
12:00 PM |
Showing the 2 most recent GMP entries.
Nephrocare Health IPO GMP & full historyLatest snapshot: 17 Dec 2025
| Category | Subscribed (x) |
|---|---|
| QIB | 16.01x |
| NII | 17.87x |
| bNII (bids above ₹10L) | 22.01x |
| sNII (bids below ₹10L) | 9.58x |
| Retail Investors | 1.68x |
| Total | 9.15x |
Showing the latest subscription snapshot.
View full subscription historyNew to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 32 | ₹14,720 |
| Retail (Max) | 13 | 416 | ₹191,360 |
| S-HNI (Min) | 14 | 448 | ₹206,080 |
| S-HNI (Max) | 67 | 2,144 | ₹986,240 |
| B-HNI (Min) | 68 | 2,176 | ₹1,000,960 |
Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 9,620,900 |
| Total Shares Offered | 9,620,900 |
Nephrocare Health Services, operating under the brand NephroPlus, is India’s and Asia's largest dialysis service provider. It addresses the critical and growing need for accessible and high-quality renal care through an extensive network of centers.
Company Growth
Founded by: Vikram Vuppala (along with co-founders) in 2009, based in Hyderabad.
Scale (As of Sep 30, 2025):
Clinic Network: Operates 519 clinics globally, including 51 in international markets (Philippines, Uzbekistan, Nepal).
The basis of allotment for Nephrocare Health IPO was finalised on 15 Dec 2025. You can check your allotment status using your PAN number or application number on the KFin Technologies Limited portal or BSE.
The Nephrocare Health IPO is expected to open in Dec 2025, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Nephrocare Health IPO is ₹438.00 - ₹460.00 per share.
As per market sources, Nephrocare Health IPO GMP is currently ₹40.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Nephrocare Health IPO stands at 9.15x overall.
The listing date for Nephrocare Health IPO is 17 Dec 2025.
No comments yet. Be the first to comment!